CymaBay Therapeutics, Inc. — Form D

CymaBay Therapeutics, Inc. of NEWARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-11. The offering totals $45.0M, of which $26.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Kurt von EmsterDirectorRedwood City, CA
Donald HillExecutive OfficerCoral Gables, FL
Paul QuinlanExecutive OfficerNew York, NY
Robert ZerbeDirectorGrand Rapids, MI
Bradley BolzonDirectorSAN DIEGO, CA
Louis LangeDirectorPalo Alto, CA
Anthony EvninDirectorCambridge, MA
Carl GoldfischerDirectorSan Diego, CA
Harold Van Wart, Ph. D.DirectorNewark, CA
Harold Van Wart, Ph. D.Executive OfficerNewark, CA
Carl G Goldfischer, M.D.DirectorNewark, CA
Pol J BoudesExecutive OfficerNewark, CA
Kurt G von EmsterDirectorNewark, CA
Hari G Kumar, Ph.D.DirectorNewark, CA
Charles A McWherter, Ph. D.Executive OfficerNewark, CA
Louis G Lange, M.D., Ph.D.DirectorNewark, CA
Robert J WillsDirectorNewark, CA
Sujal A ShahExecutive OfficerNewark, CA
Edward E Penhoet, Ph.D.DirectorHayward, CA
Edward PenhoetDirectorSeattle, WA
Daan van den NoortDirectorHaarlem, P7
David KarpfExecutive OfficerHayward, CA
Harold Van WartDirectorHayward, CA
Harold Van WartExecutive OfficerHayward, CA
Charles McWherterExecutive OfficerHayward, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2015-08-14D$325K$325K
2013-11-01D/A$45.0M$30.2M
2009-11-10D$8.6M$5.6M
2009-07-21D/A$27.7M$27.7M

More